Home / Health / Grandmother's Cancer Hope as New Drug Approved
Grandmother's Cancer Hope as New Drug Approved
19 Nov
Summary
- Breakthrough drug for incurable blood cancer now on NHS.
- Up to 800 patients annually could benefit from Talquetamab.
- Patient Sue Harley feels she can live life without cancer.
A groundbreaking drug, Talquetamab, previously only accessible through manufacturer schemes, is now available on the NHS, offering renewed hope to Sue Harley, a grandmother from Birmingham. Harley, diagnosed with incurable Myeloma in 2017, has been in remission for two years after receiving the treatment via a compassionate use program.
Her successful treatment and advocacy have contributed to the drug's general approval by health commissioners. This decision is expected to benefit up to 800 patients annually, providing them with a vital treatment option that allows them to live more normal lives and plan for the future.
The availability of Talquetamab marks a significant advancement in treating blood cancers like Myeloma, which is the third most common type. Consultant haematologist Guy Pratt highlighted the drug's role in improving patients' quality of life, expressing gratitude for its accessibility to all Myeloma patients.
